Meag Munich Ergo’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,616
| Closed | -$388K | – | 513 |
|
|
2019
Q4 | $388K | Sell |
3,616
-11,178
| -76% | -$1.2M | 0.04% | 314 |
|
|
2019
Q3 | $1.44M | Buy |
14,794
+6,323
| +75% | +$615K | 0.07% | 284 |
|
|
2019
Q2 | $1.07M | Hold |
8,471
| – | – | 0.08% | 247 |
|
|
2019
Q1 | $1.13M | Sell |
8,471
-1,541
| -15% | -$205K | 0.09% | 233 |
|
|
2018
Q4 | $985K | Buy |
+10,012
| New | +$985K | 0.12% | 245 |
|
|
2018
Q3 | – | Sell |
-10,449
| Closed | -$1.28M | – | 428 |
|
|
2018
Q2 | $1.28M | Buy |
+10,449
| New | +$1.28M | 0.08% | 239 |
|
|
2018
Q1 | – | Sell |
-21,713
| Closed | -$2.63M | – | 525 |
|
|
2017
Q4 | $2.63M | Sell |
21,713
-18,756
| -46% | -$2.27M | 0.1% | 242 |
|
|
2017
Q3 | $5.62M | Buy |
40,469
+14,956
| +59% | +$2.08M | 0.23% | 132 |
|
|
2017
Q2 | $3.12M | Buy |
25,513
+1,107
| +5% | +$135K | 0.14% | 176 |
|
|
2017
Q1 | $2.97M | Buy |
24,406
+480
| +2% | +$58.4K | 0.12% | 208 |
|
|
2016
Q4 | $2.97M | Buy |
+23,926
| New | +$2.97M | 0.14% | 180 |
|